Skip to content

Clinical trials

Heart Arrest trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Arrest Country / region: Netherlands Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20101
20111
20121
20131
20142
20151
20162
20172
20183
20194
20201
20212
20221
20233
20243
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Unknown status8
Recruiting7
Not yet recruiting2
Suspended1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Erasmus Medical Center5
Maastricht University Medical Center5
Radboud University Medical Center3
Amsterdam UMC, location VUmc2
Frisius Medisch Centrum2
Maastricht University2
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
Australian and New Zealand Intensive Care Research Centre1
Catharina Ziekenhuis Eindhoven1
Centre Hospitalier Universitaire Vaudois1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Arrest35
Out-of-Hospital Cardiac Arrest8
Death, Sudden, Cardiac5
Arrhythmias, Cardiac4
Cognitive Dysfunction3
Ventricular Fibrillation3
Acute Coronary Syndrome2
Cardiovascular Diseases2
Coma2
Hypoxia-Ischemia, Brain2

Trials

Showing 76 to 35 of 35. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.